|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current assets | |||||||
| Cash | |||||||
| Prepaid expenses and other current assets | |||||||
| Total Current Assets | |||||||
| Investments held in Trust Account | |||||||
| Total Assets | |||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||
| Current liabilities | |||||||
| Accrued expenses | |||||||
| Income taxes payable | |||||||
| Sponsor convertible note | |||||||
| Total Current Liabilities | |||||||
| Warrant liability – private placement | |||||||
| Warrant liability – public | |||||||
| Warrant liabilities – Private Placement | |||||||
| Warrant liabilities – Public Warrants | |||||||
| Deferred underwriting fee payable | |||||||
| Total Liabilities | |||||||
| Class A common stock subject to possible redemption, $0.0001 par value; 34,500,000 shares at approximately $10.04 and $10.00 per share redemption value as of September 30, 2022 and December 31, 2021, respectively | |||||||
| Stockholders’ Deficit | |||||||
| Class A common stock, $0.0001 par value; 100,000,000 shares authorized; no shares issued or outstanding (excluding 34,500,000 shares subject to possible redemption) as of September 30, 2022 and December 31, 2021 | |||||||
| Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 8,625,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021 | |||||||
| Accumulated deficit | |||||||
| Total Stockholders’ Deficit | |||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT |
Loading...